Lv31
220 积分 2023-02-07 加入
Autologous CD19‐ targeting CAR T cells in refractory juvenile dermatomyositis
10小时前
待确认
HIV immune evasin Nef enhances allogeneic CAR T cell potency
12天前
已完结
CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders
1个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
1个月前
已完结
Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells
2个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
2个月前
已关闭
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
2个月前
已关闭
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
2个月前
已关闭
HLA-independent T cell receptors for targeting tumors with low antigen density
2个月前
已完结
HIV immune evasin Nef enhances allogeneic CAR T cell potency
2个月前
已完结
皖公网安备34019202002308
